ETUNITY

Serial Number 85943883
606

Registration Progress

Application Filed
May 28, 2013
Under Examination
Dec 10, 2013
Approved for Publication
Oct 15, 2013
Published for Opposition
Oct 15, 2013
Registered

Trademark Image

ETUNITY

Basic Information

Serial Number
85943883
Filing Date
May 28, 2013
Published for Opposition
October 15, 2013
Abandonment Date
January 16, 2017
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jan 16, 2017
Classes
005

Rights Holder

Eli Lilly and Company

03
Address
Lilly Corporate Center
Indianapolis, IN 46285

Ownership History

Eli Lilly and Company

Original Applicant
03
Indianapolis, IN

Eli Lilly and Company

Owner at Publication
03
Indianapolis, IN

Legal Representation

Attorney
Robert E. Lee, Jr.

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

31 events
Date Code Type Description Documents
Jan 17, 2017 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Jan 16, 2017 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Apr 7, 2016 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 6, 2016 EX5G S SOU EXTENSION 5 GRANTED Loading...
Mar 25, 2016 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 25, 2016 EXT5 S SOU EXTENSION 5 FILED Loading...
Oct 2, 2015 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 1, 2015 EX4G S SOU EXTENSION 4 GRANTED Loading...
Sep 29, 2015 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 29, 2015 EXT4 S SOU EXTENSION 4 FILED Loading...
May 29, 2015 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 28, 2015 EX3G S SOU EXTENSION 3 GRANTED Loading...
May 15, 2015 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 15, 2015 EXT3 S SOU EXTENSION 3 FILED Loading...
Nov 5, 2014 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 4, 2014 EX2G S SOU EXTENSION 2 GRANTED Loading...
Oct 31, 2014 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 31, 2014 EXT2 S SOU EXTENSION 2 FILED Loading...
Jun 10, 2014 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 9, 2014 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jun 9, 2014 EX1G S SOU EXTENSION 1 GRANTED Loading...
May 19, 2014 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 19, 2014 EXT1 S SOU EXTENSION 1 FILED Loading...
Dec 10, 2013 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 15, 2013 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 15, 2013 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 25, 2013 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 4, 2013 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 3, 2013 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 6, 2013 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 31, 2013 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, psychiatric disorders, sleep disorders, urological disorders; antidepressants
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005